Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.
Shrestha R, Sakata-Yanagimoto M, Maie K, Oshima M, Ishihara M, Suehara Y, Fukumoto K, Nakajima-Takagi Y, Matsui H, Kato T, Muto H, Sakamoto T, Kusakabe M, Nannya Y, Makishima H, Ueno H, Saiki R, Ogawa S, Chiba K, Shiraishi Y, Miyano S, Mouly E, Bernard OA, Inaba T, Koseki H, Iwama A, Chiba S.
Shrestha R, et al. Among authors: makishima h.
Blood Adv. 2020 Mar 10;4(5):845-854. doi: 10.1182/bloodadvances.2019001324.
Blood Adv. 2020.
PMID: 32126143
Free PMC article.